Top

Published in:

Open Access 01-12-2014 | Oral presentation

Efficacy of second-time vacuum-assisted breast excision in the management of screen-detected high-risk breast lesions

Authors: M Morgan, R Patel, W Teh

Published in: Breast Cancer Research | Special Issue 1/2014

Excerpt

Surgical excision of breast lesions is usually required for high-risk (B3) lesions or radiological pathological discordance. The risk of underestimation of malignancy is 45 to 50% for 14G core biopsy and 20 to 25% for vacuum-assisted biopsies (VAB). …

Title: Efficacy of second-time vacuum-assisted breast excision in the management of screen-detected high-risk breast lesions
Authors: M Morgan
R Patel
W Teh
Publication date: 01-12-2014
Publisher: BioMed Central
Published in: Breast Cancer Research / Issue Special Issue 1/2014
Electronic ISSN: 1465-542X
DOI: https://doi.org/10.1186/bcr3698

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras

Prof. Fabrice Barlesi

Developed by: Springer Medicine

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Special Issue 1/2014

PB.43. A clinical audit of breast cancer staging

PB.6. Management of radial scars on core biopsy

Multidetector CT Improving Surgical Outcomes in Breast Cancer (MISO BC)

PB.20. Audit of 5 years of routine screening mammography of the reconstructed breast

PB.26. MRI-guided breast biopsy in Leeds: 12 years' experience

PB.8. Ultrasound-guided excision of fibroadenomas: 9 years' experience in a British breast unit

Keynote webinar | Spotlight on antibody–drug conjugates in cancer